[236 Pages] The global ePharmacy market is projected to expand at 14.3% CAGR to reach a market valuation of US$ 351.9 billion by the end of 2033, up from the US$ 81.5 billion recorded for 2022.
“The growth of the global ePharmacy market is being driven by pharmacies efficiency in providing affordable medicinal products as well as increased e-commerce penetration”
| Attribute | Details |
|---|---|
| ePharmacies Market Size (2023) | US$ 92.4 Billion |
| Forecasted Market Value (2033) | US$ 351.9 Billion |
| Value CAGR (2023 to 2033) | 14.3% |
| Collective Value Share: Top 5 Countries (2022) | 58.4% |
| Key Market Players | Netmeds Marketplace Ltd, EasyMedico, Medlife, Amazon. Inc, Apotek, The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Express Scripts, CVS Health, Optum, Inc., L Rowland & Co (Retail) Ltd, Zur Rose Group AG, McKesson Corporation, SHOP-APOTHEKE EUROPE N.V., UK Meds Direct Ltd., Walgreens Boots Alliance, Inc., DocMorris |
There is a rising demand for mail-order pharmaceuticals as e-commerce and internet use become more widespread. Worldwide, many online pharmacies, also called ePharmacies, offer doorstep delivery and medication dispensing for prescription and over-the-counter drugs. Since the introduction of ePharmacy, patients no longer need to visit the pharmacist, and ease of ordering over various supplier platforms has resulted in market development.
Leading ePharmacy firms also provide medications at lower costs than conventional brick-and-mortar pharmacies. As a result of more significant investment by e-commerce big players in the healthcare sector, the ePharmacy market is anticipated to grow at a significant rate over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The ePharmacies market expanded at a CAGR of 12.9% during the historical period (2017 to 2022) and reached a market value of US$ 81.4 billion in 2022.
A large patient pool worldwide chose doorstep delivery of medical supplies because of the unavailability of some prescription medicines at retail pharmacy stores. ePharmacies reduce the need for senior citizens and people with chronic illnesses to rely on other parties to get their medications and medical supplies. Likewise, increased internet usage and awareness are anticipated to increase ePharmacy market sales.
The growing global accessibility of the internet and online commercial platforms and their products has provided various lucrative opportunities for ePharmacy to build a large customer base in developed as well as growing economies. Furthermore, youngsters of the current population heavily rely on online shopping for products like cosmetics/cosmeceuticals and over-the-counter pharmaceuticals.
The rapid development of the internet, the rise of digital health or eHealth, the transition from direct doctor-patient interactions toward self-diagnosis, consumer experience with online purchases, the simplicity of mail-order commerce, and distance selling all contribute to the growth of the online pharmacy market.
H1-H2 Update
| Market Statistics | Details |
|---|---|
| Jan–Jun (H1), 2021 (A) | 10.89% |
| Jul–Dec (H2), 2021 (A) | 14.09% |
| Jan–Jun (H1),2022 Projected (P) | 10.37% |
| Jan–Jun (H1),2022 Outlook (O) | 11.19% |
| Jul–Dec (H2), 2022 Outlook (O) | 14.66% |
| Jul–Dec (H2), 2022 Projected (P) | 13.71% |
| Jan–Jun (H1), 2023 Projected (P) | 11.21% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 82↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 30↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 94↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 56↑ |
The growth of the ePharmacy market is being hampered by the existence of fraudulent online pharmacies and counterfeit products. Secondly, since these unauthorized pharmacies sell pharmaceuticals that the FDA has not approved, there is a higher chance that one will get contaminated, fake medications from them that contain the incorrect active components.
Principal Consultant
Smartphone adoption is expanding, which is helping the ePharmacy Market grow. The adoption rate of smartphones was around 65.0% in 2019 and is predicted to reach 80.0% by 2025, according to The Mobile Economy 2020.
The expanding healthcare industry and the high operating expenses have made it necessary to use ePharmacy platforms to reduce operational costs. Demand for numerous healthcare products, especially medications, is rising as chronic conditions become more common. This represents a greater opportunity of online modes of drug procurement worldwide.
Over the course of the forecast period, the market is anticipated to grow as more e-pharmacies are established in emerging nations.
An increase in internet consumers, more accessible access to web-based and online services, and an increase in the use of e-prescriptions in healthcare facilities are all factors contributing to the growth of the e-pharmacy market.
For instance, Phoenix UK acquired Co-op Health in March 2021, a digital prescription service that enables people to order medication through an application for pickup at a nearby pharmacy or home delivery. Due to the increase in service usage and expansion, such acquisitions in the e-pharmacy market are anticipated to fuel market growth.
| Country | USA |
|---|---|
| Market Share (2023) | 34.6% |
| Market Share (2033) | 44.0% |
| BPS Analysis | 938 |
| Country | China |
|---|---|
| Market Share (2023) | 6.6% |
| Market Share (2033) | 5.4% |
| BPS Analysis | -126 |
| Country | Germany |
|---|---|
| Market Share (2023) | 6.3% |
| Market Share (2033) | 7.4% |
| BPS Analysis | 102 |
| Country | Australia |
|---|---|
| Market Share (2023) | 5.9% |
| Market Share (2033) | 5.8% |
| BPS Analysis | -4 |
| Country | Japan |
|---|---|
| Market Share (2023) | 5.3% |
| Market Share (2033) | 5.1% |
| BPS Analysis | -15 |
The United States is set to hold a share of around 34.6% of the global ePharmacy Market in 2023.
Some of the key drivers driving the growth of the USA market are the rising utilization of e-commerce platforms, an ageing population, and developed healthcare infrastructure. Additionally, the majority of USA citizens are involved with ePharmacy and the evolving tendency toward the direct-to-patient approach.
The consumer-friendly online experiences made possible by the digital world as well as other advanced services are further fueling the expansion of the USA market as a whole. As a result, in December 2020, the cardiovascular pharmaceutical company, Medicure Inc., declared that it formalized a deal to acquire Marley Drug, Inc. through its wholly-owned USA subsidiary, Medicure Pharma Inc.
Germany is set to hold a share of 6.3% of the global market in 2023.
The ePharmacy market trend is anticipated to be positively impacted by the general population's reliance on online delivery of consumer products including OTC healthcare products such as vitamin pills, supplements, cosmetics, and others. Online pharmaceutical procurement is anticipated to rise in the Germany as a result of an increase in the number of patients using home care services and treatments as a result of excessive healthcare expenditure in hospitals.
China is set to hold a share of 6.6% of the global market in 2023.
In China, the e-pharmacy industry is evolving rapidly due to new rules and the entry of new competitors. Hospitals and governments are collaborating with online pharmacies on pilot projects to let patients order medications online with valid prescriptions. China's enormous population indicates numerous patients suffering from chronic diseases, and there is also an increasing public awareness of online pharmacies, all these factors are expected to uplift the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over-the-counter product segments are expected to hold a market share of 71.4% in 2023 globally.
As the general public becomes more informed and aware of the primary treatment for common ailments, the need for OTC medications will increase. Sales in the ePharmacy market will be driven by the availability of a large selection of over-the-counter drugs for numerous common disorders like the cold and flu. Additionally, a legal framework that promotes transitioning from Rx to OTC will boost category sales growth.
On the other hand, consumers are increasingly choosing OTC drugs over prescription drugs due to their increased affordability and accessibility. The factors above will increase the number of products available in the ePharmacy market.
To gain a competitive edge and solidify their market positions, market participants are exploring a number of growth strategies. The worldwide ePharmacy market is expected to have significant growth due to increasing consumer demands. Online retail platforms' easy access to regulated prescription drugs such as stimulants, painkillers, and tranquillizing hypnotics is indirectly contributing to market growth.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the ePharmacy market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, Asia-Pacific excluding Japan, and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product and region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
The ePharmacy market is valued at US$ 92.4 billion in 2023.
The ePharmacy market is estimated to surpass US$ 351.9 billion by 2033.
The ePharmacy market is projected to experience a CAGR of 14.3% through 2033.
The United States ePharmacy market commands 34.6% of global value in 2023.
The ePharmacy market attained a value of US$ 81.4 billion by 2022, with a CAGR of 12.9%
1. Executive Summary | ePharmacy Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Growing Popularity of Market 4.1. A New Generation adopting solutions 4.2. Branded products at low cost are behind the Market growth 5. market is Changing- Training Industry 5.1. Evolution and Challenges in the Organization 5.2. Delivery of in Short Time Slots 6. Key Market Trends 6.1. Key Trends Impacting the Market 6.2. Formulation and Product Development Trends 7. Key Success Factors 7.1. Top Companies 7.2. PESTLE Analysis of Market 7.3. Porter’s Five Force 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Organization spending on R&D 8.1.2. Pharmaceutical Industry Contribution to GDP 8.1.3. Outlook 8.1.4. Outbreak of Covid-19 Pandemic 8.1.5. Economic Instability 8.1.6. Impact of Online Sale 8.2. Forecast Factors - Relevance & Impact 8.2.1. Global Industry Assessment 8.2.2. Global Services Market 8.2.3. Global Pricing Assessment 8.2.4. Global Industry outlook 8.3. Market Dynamics 8.3.1. Drivers 8.3.2. Restraints 8.3.3. Opportunity Analysis 9. Global Market Demand (in Value US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 9.2. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis, by Product, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Product, 2023 to 2033 10.3.1. Over the Counter Product 10.3.2. Prescription Medicine 10.4. Market Attractiveness Analysis, by Product 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis, by Region, 2017 to 2022 11.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. The Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis, by Region 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 12.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 12.3.1. By Country 12.3.1.1. USA 12.3.1.2. Canada 12.3.2. By Product 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.5. Market Trends 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. USA Market Analysis 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy 12.7.1.2.1. By Product 12.7.2. Canada Market Analysis 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy 12.7.2.2.1. By Product 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 13.3.1. By Country 13.3.1.1. Mexico 13.3.1.2. Brazil 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.5. Market Trends 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. Mexico Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy 13.7.1.2.1. By Product 13.7.2. Brazil Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy 13.7.2.2.1. By Product 13.7.3. Argentina Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy 13.7.3.2.1. By Product 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. United Kingdom 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Product 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.5. Market Trends 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. Germany Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy 14.7.1.2.1. By Product 14.7.2. Italy Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy 14.7.2.2.1. By Product 14.7.3. France Market Analysis 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy 14.7.3.2.1. By Product 14.7.4. United Kingdom Market Analysis 14.7.4.1. Introduction 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy 14.7.4.2.1. By Product 14.7.5. Spain Market Analysis 14.7.5.1. Introduction 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy 14.7.5.2.1. By Product 14.7.6. BENELUX Market Analysis 14.7.6.1. Introduction 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy 14.7.6.2.1. By Product 14.7.7. Russia Market Analysis 14.7.7.1. Introduction 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy 14.7.7.2.1. By Product 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market End User (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product 15.4. Market Attractiveness Analysis 15.4.1. By Product 15.5. Market Trends 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. China Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy 15.7.1.2.1. By Product 15.7.2. Japan Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy 15.7.2.2.1. By Product 15.7.3. South Korea Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy 15.7.3.2.1. By Product 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Malaysia 16.3.1.4. Thailand 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.5. Market Trends 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. India Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy 16.7.1.2.1. By Product 16.7.2. Indonesia Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy 16.7.2.2.1. By Product 16.7.3. Malaysia Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy 16.7.3.2.1. By Product 16.7.4. Thailand Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy 16.7.4.2.1. By Product 17. Oceania Market 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. Australia Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy 17.7.1.2.1. By Product 17.7.2. New Zealand Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy 17.7.2.2.1. By Product 18. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Türkiye 18.3.1.3. South Africa 18.3.1.4. North Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Product 18.4. Market Attractiveness Analysis 18.4.1. By Product 18.5. Market Trends 18.6. Drivers and Restraints - Impact Analysis 18.7. Country Level Analysis & Forecast 18.7.1. GCC Countries Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy 18.7.1.2.1. By Product 18.7.2. Türkiye Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy 18.7.2.2.1. By Product 18.7.3. South Africa Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy 18.7.3.2.1. By Product 18.7.4. North Africa Market Analysis 18.7.4.1. Introduction 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy 18.7.4.2.1. By Product 19. Market Structure Analysis 19.1. Market Analysis, by Tier of Companies 19.2. Market Share Analysis of Top Players 19.3. Market Presence Analysis 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Netmeds Marketplace Ltd. 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Sales Footprint 20.3.1.4. Key Financials 20.3.1.5. SWOT Analysis 20.3.1.6. Strategy Overview 20.3.1.6.1. Marketing Strategy 20.3.1.6.2. Product Strategy 20.3.1.6.3. Channel Strategy 20.3.2. EasyMedico 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Sales Footprint 20.3.2.4. Key Financials 20.3.2.5. SWOT Analysis 20.3.2.6. Strategy Overview 20.3.2.6.1. Marketing Strategy 20.3.2.6.2. Product Strategy 20.3.2.6.3. Channel Strategy 20.3.3. Medlife 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Sales Footprint 20.3.3.4. Key Financials 20.3.3.5. SWOT Analysis 20.3.3.6. Strategy Overview 20.3.3.6.1. Marketing Strategy 20.3.3.6.2. Product Strategy 20.3.3.6.3. Channel Strategy 20.3.4. Amazon. Inc 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Sales Footprint 20.3.4.4. Key Financials 20.3.4.5. SWOT Analysis 20.3.4.6. Strategy Overview 20.3.4.6.1. Marketing Strategy 20.3.4.6.2. Product Strategy 20.3.4.6.3. Channel Strategy 20.3.5. Apotek 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Sales Footprint 20.3.5.4. Key Financials 20.3.5.5. SWOT Analysis 20.3.5.6. Strategy Overview 20.3.5.6.1. Marketing Strategy 20.3.5.6.2. Product Strategy 20.3.5.6.3. Channel Strategy 20.3.6. The Kroger Co. 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Sales Footprint 20.3.6.4. Key Financials 20.3.6.5. SWOT Analysis 20.3.6.6. Strategy Overview 20.3.6.6.1. Marketing Strategy 20.3.6.6.2. Product Strategy 20.3.6.6.3. Channel Strategy 20.3.7. Walgreen Co. 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Sales Footprint 20.3.7.4. Key Financials 20.3.7.5. SWOT Analysis 20.3.7.6. Strategy Overview 20.3.7.6.1. Marketing Strategy 20.3.7.6.2. Product Strategy 20.3.7.6.3. Channel Strategy 20.3.8. Giant Eagle, Inc. 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Sales Footprint 20.3.8.4. Key Financials 20.3.8.5. SWOT Analysis 20.3.8.6. Strategy Overview 20.3.8.6.1. Marketing Strategy 20.3.8.6.2. Product Strategy 20.3.8.6.3. Channel Strategy 20.3.9. Walmart 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Sales Footprint 20.3.9.4. Key Financials 20.3.9.5. SWOT Analysis 20.3.9.6. Strategy Overview 20.3.9.6.1. Marketing Strategy 20.3.9.6.2. Product Strategy 20.3.9.6.3. Channel Strategy 20.3.10. Express Scripts 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Sales Footprint 20.3.10.4. Key Financials 20.3.10.5. SWOT Analysis 20.3.10.6. Strategy Overview 20.3.10.6.1. Marketing Strategy 20.3.10.6.2. Product Strategy 20.3.10.6.3. Channel Strategy 20.3.11. CVS Health 20.3.11.1. Overview 20.3.11.2. Product Portfolio 20.3.11.3. Sales Footprint 20.3.11.4. Key Financials 20.3.11.5. SWOT Analysis 20.3.11.6. Strategy Overview 20.3.11.6.1. Marketing Strategy 20.3.11.6.2. Product Strategy 20.3.11.6.3. Channel Strategy 20.3.12. Optum, Inc. 20.3.12.1. Overview 20.3.12.2. Product Portfolio 20.3.12.3. Sales Footprint 20.3.12.4. Key Financials 20.3.12.5. SWOT Analysis 20.3.12.6. Strategy Overview 20.3.12.6.1. Marketing Strategy 20.3.12.6.2. Product Strategy 20.3.12.6.3. Channel Strategy 20.3.13. L Rowland & Co (Retail) Ltd 20.3.13.1. Overview 20.3.13.2. Product Portfolio 20.3.13.3. Sales Footprint 20.3.13.4. Key Financials 20.3.13.5. SWOT Analysis 20.3.13.6. Strategy Overview 20.3.13.6.1. Marketing Strategy 20.3.13.6.2. Product Strategy 20.3.13.6.3. Channel Strategy 20.3.14. Zur Rose Group AG 20.3.14.1. Overview 20.3.14.2. Product Portfolio 20.3.14.3. Sales Footprint 20.3.14.4. Key Financials 20.3.14.5. SWOT Analysis 20.3.14.6. Strategy Overview 20.3.14.6.1. Marketing Strategy 20.3.14.6.2. Product Strategy 20.3.14.6.3. Channel Strategy 20.3.15. McKesson Corporation 20.3.15.1. Overview 20.3.15.2. Product Portfolio 20.3.15.3. Sales Footprint 20.3.15.4. Key Financials 20.3.15.5. SWOT Analysis 20.3.15.6. Strategy Overview 20.3.15.6.1. Marketing Strategy 20.3.15.6.2. Product Strategy 20.3.15.6.3. Channel Strategy 20.3.16. SHOP-APOTHEKE EUROPE N.V. 20.3.16.1. Overview 20.3.16.2. Product Portfolio 20.3.16.3. Sales Footprint 20.3.16.4. Key Financials 20.3.16.5. SWOT Analysis 20.3.16.6. Strategy Overview 20.3.16.6.1. Marketing Strategy 20.3.16.6.2. Product Strategy 20.3.16.6.3. Channel Strategy 20.3.17. UK Meds Direct Ltd. 20.3.17.1. Overview 20.3.17.2. Product Portfolio 20.3.17.3. Sales Footprint 20.3.17.4. Key Financials 20.3.17.5. SWOT Analysis 20.3.17.6. Strategy Overview 20.3.17.6.1. Marketing Strategy 20.3.17.6.2. Product Strategy 20.3.17.6.3. Channel Strategy 20.3.18. Walgreens Boots Alliance, Inc. 20.3.18.1. Overview 20.3.18.2. Product Portfolio 20.3.18.3. Sales Footprint 20.3.18.4. Key Financials 20.3.18.5. SWOT Analysis 20.3.18.6. Strategy Overview 20.3.18.6.1. Marketing Strategy 20.3.18.6.2. Product Strategy 20.3.18.6.3. Channel Strategy 20.3.19. DocMorris 20.3.19.1. Overview 20.3.19.2. Product Portfolio 20.3.19.3. Sales Footprint 20.3.19.4. Key Financials 20.3.19.5. SWOT Analysis 20.3.19.6. Strategy Overview 20.3.19.6.1. Marketing Strategy 20.3.19.6.2. Product Strategy 20.3.19.6.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
ePharmacy Market
